The exosome therapies market is expected to experience significant growth due to increased interest in regenerative medicine, cancer treatments, and drug delivery systems. Leading Indications ...

The exosome therapies market is expected to experience significant growth due to increased interest in regenerative medicine, ...

The exosome diagnostic and therapeutic market is projected to grow at a CAGR of 9.1% from 2024 to 2034. Market valuation will increase from USD 88.56 million in 2024 to USD 211.6 million by 2034.

称为外泌体（exosome）的细胞外囊泡（extracellular vesicles）是一种脱落的微小细胞碎片，在体内传播并传递生化信号。在一项新的研究中，来自渥太华医院和渥太华大学的研究人员发现了 ...

Researchers from Nanjing University have published a review in ExRNA, shedding light on the critical role of RNAkines in ...

A recent study published on December 19, 2024, in the ExRNA journal highlights research from the Novosibirsk Institute of ...

Appointment adds business, market and partner development expertise to FYR board Addition highlights FYR’s evolution into ...

01 邀请辞2025年4月17日-18日第九届细胞外囊泡前沿与转化大会将在西安举办，本次会议由生物谷主办，中国研究型医院学会细胞外囊泡研究与应用专业委员会(CSEV)、Interdisciplinary Medicine ...

A recent study published on December 19, 2024, in the ExRNA journal highlights research from the Novosibirsk Institute of ...

EV Biologics, Inc. (OTCMKTS:YECO – Get Free Report) shot up 83.1% during trading on Tuesday . The company traded as high as $0.22 and last traded at $0.17. 780 shares were traded during trading, a ...

MBR Genomics partners with Axio BioPharma to make MKLP1 Pro antibodies commercially available: Madison, Wisconsin Tuesday, January 7, 2025, 15:00 Hrs [IST] In a milestone for cel ...